RSLS Annual Revenue
$8.68 M
-$2.56 M-22.79%
31 December 2023
Summary:
As of January 23, 2025, RSLS annual revenue is $8.68 million, with the most recent change of -$2.56 million (-22.79%) on December 31, 2023. During the last 3 years, it has fallen by -$2.62 million (-23.20%). RSLS annual revenue is now -42.49% below its all-time high of $15.09 million, reached on December 31, 2019.RSLS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RSLS Quarterly Revenue
$2.29 M
+$327.00 K+16.64%
30 September 2024
Summary:
As of January 23, 2025, RSLS quarterly revenue is $2.29 million, with the most recent change of +$327.00 thousand (+16.64%) on September 30, 2024. Over the past year, it has increased by +$137.00 thousand (+6.36%). RSLS quarterly revenue is now -48.49% below its all-time high of $4.45 million, reached on June 30, 2019.RSLS Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RSLS TTM Revenue
$8.18 M
+$137.00 K+1.70%
30 September 2024
Summary:
As of January 23, 2025, RSLS TTM revenue is $8.18 million, with the most recent change of +$137.00 thousand (+1.70%) on September 30, 2024. Over the past year, it has dropped by -$1.62 million (-16.55%). RSLS TTM revenue is now -45.77% below its all-time high of $15.09 million, reached on December 31, 2019.RSLS TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RSLS Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.8% | +6.4% | -16.6% |
| 3 y3 years | -23.2% | -38.2% | -40.1% |
| 5 y5 years | +1329.7% | -36.4% | -32.6% |
RSLS Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -36.2% | at low | -27.1% | +17.9% | -39.8% | +1.7% |
| 5 y | 5-year | -42.5% | at low | -43.4% | +34.7% | -45.8% | +1.7% |
| alltime | all time | -42.5% | +2871.9% | -48.5% | >+9999.0% | -45.8% | >+9999.0% |
ReShape Lifesciences Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.29 M(+16.6%) | $8.18 M(+1.7%) |
| June 2024 | - | $1.97 M(+1.1%) | $8.05 M(-3.5%) |
| Mar 2024 | - | $1.94 M(-1.9%) | $8.34 M(-4.0%) |
| Dec 2023 | $8.68 M(-22.8%) | $1.98 M(-8.0%) | $8.68 M(-11.5%) |
| Sept 2023 | - | $2.15 M(-4.4%) | $9.81 M(-6.2%) |
| June 2023 | - | $2.25 M(-1.4%) | $10.45 M(-5.8%) |
| Mar 2023 | - | $2.29 M(-26.5%) | $11.09 M(-1.4%) |
| Dec 2022 | $11.24 M(-17.4%) | $3.11 M(+11.2%) | $11.24 M(-0.3%) |
| Sept 2022 | - | $2.80 M(-3.3%) | $11.27 M(-7.5%) |
| June 2022 | - | $2.89 M(+18.5%) | $12.18 M(-5.0%) |
| Mar 2022 | - | $2.44 M(-22.3%) | $12.82 M(-5.7%) |
| Dec 2021 | $13.60 M(+20.4%) | $3.14 M(-15.3%) | $13.60 M(-0.5%) |
| Sept 2021 | - | $3.71 M(+5.1%) | $13.66 M(+0.8%) |
| June 2021 | - | $3.53 M(+9.6%) | $13.56 M(+15.6%) |
| Mar 2021 | - | $3.22 M(+0.4%) | $11.73 M(+3.8%) |
| Dec 2020 | $11.30 M(-25.1%) | $3.21 M(-11.0%) | $11.30 M(-6.9%) |
| Sept 2020 | - | $3.60 M(+111.6%) | $12.14 M(+0.7%) |
| June 2020 | - | $1.70 M(-39.0%) | $12.06 M(-18.6%) |
| Mar 2020 | - | $2.79 M(-31.1%) | $14.80 M(-1.9%) |
| Dec 2019 | $15.09 M | $4.05 M(+15.2%) | $15.09 M(+31.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $3.52 M(-21.0%) | $11.49 M(+43.9%) |
| June 2019 | - | $4.45 M(+44.8%) | $7.98 M(+125.4%) |
| Mar 2019 | - | $3.07 M(+583.1%) | $3.54 M(+483.5%) |
| Dec 2018 | $607.00 K(+6.6%) | $450.00 K(+5525.0%) | $607.00 K(+160.5%) |
| Sept 2018 | - | $8000.00(-20.0%) | $233.00 K(-60.2%) |
| June 2018 | - | $10.00 K(-92.8%) | $585.00 K(-12.4%) |
| Mar 2018 | - | $139.00 K(+82.9%) | $668.10 K(+17.4%) |
| Dec 2017 | $569.20 K(-27.6%) | $76.00 K(-78.9%) | $569.10 K(-10.4%) |
| Sept 2017 | - | $360.00 K(+286.7%) | $635.00 K(+11.1%) |
| June 2017 | - | $93.10 K(+132.8%) | $571.80 K(-24.2%) |
| Mar 2017 | - | $40.00 K(-71.8%) | $754.70 K(-4.1%) |
| Dec 2016 | $786.70 K(+169.4%) | $141.90 K(-52.2%) | $786.70 K(-0.9%) |
| Sept 2016 | - | $296.80 K(+7.5%) | $793.80 K(+41.5%) |
| June 2016 | - | $276.00 K(+283.3%) | $561.00 K(+54.1%) |
| Mar 2016 | - | $72.00 K(-51.7%) | $364.00 K(+24.7%) |
| Dec 2015 | $292.00 K(-6.3%) | $149.00 K(+132.8%) | $292.00 K(+104.2%) |
| Sept 2015 | - | $64.00 K(-19.0%) | $143.00 K(+81.0%) |
| June 2015 | - | $79.00 K(-58.1%) | $79.00 K(-74.6%) |
| Dec 2012 | $311.50 K | - | - |
| June 2012 | - | $188.40 K(+53.0%) | $311.50 K(+153.0%) |
| Mar 2012 | - | $123.10 K | $123.10 K |
FAQ
- What is ReShape Lifesciences annual revenue?
- What is the all time high annual revenue for ReShape Lifesciences?
- What is ReShape Lifesciences annual revenue year-on-year change?
- What is ReShape Lifesciences quarterly revenue?
- What is the all time high quarterly revenue for ReShape Lifesciences?
- What is ReShape Lifesciences quarterly revenue year-on-year change?
- What is ReShape Lifesciences TTM revenue?
- What is the all time high TTM revenue for ReShape Lifesciences?
- What is ReShape Lifesciences TTM revenue year-on-year change?
What is ReShape Lifesciences annual revenue?
The current annual revenue of RSLS is $8.68 M
What is the all time high annual revenue for ReShape Lifesciences?
ReShape Lifesciences all-time high annual revenue is $15.09 M
What is ReShape Lifesciences annual revenue year-on-year change?
Over the past year, RSLS annual revenue has changed by -$2.56 M (-22.79%)
What is ReShape Lifesciences quarterly revenue?
The current quarterly revenue of RSLS is $2.29 M
What is the all time high quarterly revenue for ReShape Lifesciences?
ReShape Lifesciences all-time high quarterly revenue is $4.45 M
What is ReShape Lifesciences quarterly revenue year-on-year change?
Over the past year, RSLS quarterly revenue has changed by +$137.00 K (+6.36%)
What is ReShape Lifesciences TTM revenue?
The current TTM revenue of RSLS is $8.18 M
What is the all time high TTM revenue for ReShape Lifesciences?
ReShape Lifesciences all-time high TTM revenue is $15.09 M
What is ReShape Lifesciences TTM revenue year-on-year change?
Over the past year, RSLS TTM revenue has changed by -$1.62 M (-16.55%)